Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2012 Sep 22;146(5):1126–1132.e10. doi: 10.1016/j.jtcvs.2012.08.061

TABLE 2.

Preoperative risk factors associated with lower (worse) postoperative TAPSE

Factor Estimate ± SE P
value
Reliability
(%)*
Overall
  Higher preoperative TR 100
    1+vs 0 0.13 ± 0.047 .006
    2+vs 0 0.45 ± 0.047 <.0001
    3+/4+vs 0 0.50 ± 0.051 <.0001
  Higher heart rate −0.16 ± 0.079 .05 60
  Larger LA area in systole −4.9 ± 1.8 .005 99
  Lower LVejection fraction§ 0.22 ± 0.087 .01 65
  Higher BUN 0.052 ± 0.019 .005 77
Early phase
  Shorter RV base to apex length −0.76 ± 0.41 .06 85
  TV procedure 1.04 ± 0.52 .03
Late phase
  Lower TV fractional shortening# −7.04 ± 4.02 .07 88
  Higher bilirubin** 0.72 ± 0.24 .006 83
  No TV procedure −0.72 ± 0.26 .006

BUN, Blood urea nitrogen; LA, left atrial; LV, left ventricular; RV, right ventricular; SE, standard error; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation; TV, tricuspid valve.

*

Percentage of times factor appeared in 500 bootstrap models.

(75/heart rate), inverse transformation.

(1/LA area in systole), inverse transformation.

§

(50/LV ejection fraction), inverse transformation.

(BUN/20)2, squared transformation.

(RV base to apex length/7)2, squared transformation.

#

(TV fractional shortening)2, squared transformation.

**

Ln(bilirubin), natural logarithmic transformation.